- $22.93m
- $103.59m
- $159.83m
Brief: MariMed Q2 Adjusted EBITDA USD 3.9 Million
Cannabis operator MariMed Q1 revenue rises, adjusted EBITDA improves
Brief: MariMed Q1 Adjusted EBITDA USD 3.6 Million
MariMed Q4 revenue beats estimates
Brief: MariMed Q4 Adjusted EBITDA USD 4.4 Million
MariMed Q3 revenue misses analyst expectations
Brief: MariMed Q3 Adjusted EBITDA USD 5.1 Million
Brief: Marimed Announces Exit From Missouri Market
Brief: MariMed Q2 Adjusted EBITDA USD 4.9 Million
Brief: MariMed Q1 Adjusted EBITDA USD 2.6 Million
Brief: Marimed Promotes Ryan Crandall To Chief Commercial Officer
Brief: MariMed Q4 Adjusted EBITDA USD 5.9 Million
Brief: MariMed Q3 Adjusted EBITDA USD 4.7 Million
Brief: MariMed Announces Appointment Of Mario Pinho As Chief Financial Officer
Brief: MariMed Q2 Adjusted EBITDA USD 4.4 Million
Brief: MariMed Closes Acquisition Of Second Maryland Dispensary
Brief: MariMed Q1 Adjusted EBITDA USD 4.7 Million
Brief: MariMed Q4 Adjusted EBITDA USD 5.2 Million
Brief: MariMed Closes $58.7 Mln Debt Refinancing